438 related articles for article (PubMed ID: 16386795)
1. Zinc(II) complexes with potent cyclin-dependent kinase inhibitors derived from 6-benzylaminopurine: synthesis, characterization, X-ray structures and biological activity.
Trávnícek Z; Krystof V; Sipl M
J Inorg Biochem; 2006 Feb; 100(2):214-25. PubMed ID: 16386795
[TBL] [Abstract][Full Text] [Related]
2. Mixed ligand complexes of platinum(II) and palladium(II) with cytokinin-derived compounds Bohemine and Olomoucine: X-ray structure of [Pt(BohH+-N7)Cl(3)].9/5H2O [Boh=6-(benzylamino)-2-[(3-(hydroxypropyl)-amino]-9-isopropylpurine, Bohemine].
Trávnícek Z; Malon M; Zatloukal M; Dolezal K; Strnad M; Marek J
J Inorg Biochem; 2003 Apr; 94(4):307-16. PubMed ID: 12667701
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.
Trávnícek Z; Szucová L; Popa I
J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, spectral study and cytotoxicity of platinum(II) complexes with 2,9-disubstituted-6-benzylaminopurines.
Malon M; Trávnícek Z; Marek R; Strnad M
J Inorg Biochem; 2005 Nov; 99(11):2127-38. PubMed ID: 16143400
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P
J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
[TBL] [Abstract][Full Text] [Related]
6. Preparation, physicochemical properties and biological activity of copper(II) complexes with 6-(2-chlorobenzylamino)purine (HL1) or 6-(3-chlorobenzylamino)purine (HL2). The single-crystal X-ray structure of.
Trávnícek Z; Malon M; Sindelál Z; Dolezal K; Rolcík J; Krystof V; Strnad M; Marek J
J Inorg Biochem; 2001 Mar; 84(1-2):23-32. PubMed ID: 11330478
[TBL] [Abstract][Full Text] [Related]
7. The first iron(III) complexes with cyclin-dependent kinase inhibitors: Magnetic, spectroscopic (IR, ES+ MS, NMR, (57)Fe Mössbauer), theoretical, and biological activity studies.
Trávnícek Z; Popa I; Cajan M; Zboril R; Krystof V; Mikulík J
J Inorg Biochem; 2010 Apr; 104(4):405-17. PubMed ID: 20056279
[TBL] [Abstract][Full Text] [Related]
8. Novel platinum(II) and palladium(II) complexes with cyclin-dependent kinase inhibitors: synthesis, characterization and antitumour activity.
Szucová L; Trávnícek Z; Zatloukal M; Popa I
Bioorg Med Chem; 2006 Jan; 14(2):479-91. PubMed ID: 16198575
[TBL] [Abstract][Full Text] [Related]
9. Zinc(II) complexes derived from pyridine-2-carbaldehyde thiosemicarbazone and (1E)-1-pyridin-2-ylethan-1-one thiosemicarbazone. Synthesis, crystal structures and antiproliferative activity of zinc(II) complexes.
Kovala-Demertzi D; Yadav PN; Wiecek J; Skoulika S; Varadinova T; Demertzis MA
J Inorg Biochem; 2006 Sep; 100(9):1558-67. PubMed ID: 16828164
[TBL] [Abstract][Full Text] [Related]
10. Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: preparation, characterization and in vitro cytotoxicity.
Trávnícek Z; Starha P; Popa I; Vrzal R; Dvorák Z
Eur J Med Chem; 2010 Oct; 45(10):4609-14. PubMed ID: 20692737
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, crystal structures, and biological evaluation of Cu(II) and Zn(II) complexes of 2-benzoylpyridine Schiff bases derived from S-methyl- and S-phenyldithiocarbazates.
Li MX; Zhang LZ; Chen CL; Niu JY; Ji BS
J Inorg Biochem; 2012 Jan; 106(1):117-25. PubMed ID: 22112848
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structural characterization and influence on the phagocytic activity of human neutrophils of thiazoline and thiazine derivative ligands and their zinc(II) complexes.
Barros-García FJ; Bernalte-García A; Lozano-Vila AM; Luna-Giles F; Pariente JA; Pedrero-Marín R; Rodríguez AB
J Inorg Biochem; 2006 Nov; 100(11):1861-70. PubMed ID: 16963122
[TBL] [Abstract][Full Text] [Related]
13. Zinc(II), cadmium(II) and mercury(II) complexes of the vitamin B1 antagonist oxythiamine.
Casas JS; Castellano EE; Couce MD; Ellena J; Sánchez A; Sordo J; Taboada C
J Inorg Biochem; 2006 Jan; 100(1):124-32. PubMed ID: 16337684
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles.
Sánchez-Guadarrama O; López-Sandoval H; Sánchez-Bartéz F; Gracia-Mora I; Höpfl H; Barba-Behrens N
J Inorg Biochem; 2009 Sep; 103(9):1204-13. PubMed ID: 19628280
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures, spectroscopic properties of new cobalt(II), nickel(II), zinc(II) and palladium(II) complexes derived from 2-acetyl-5-chloro thiophene thiosemicarbazone: Anticancer evaluation.
Şen B; Kalhan HK; Demir V; Güler EE; Kayalı HA; Subaşı E
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():550-559. PubMed ID: 30813058
[TBL] [Abstract][Full Text] [Related]
16. Synthetic, spectral, magnetic and in vitro cytotoxic activity studies of cobalt(II) complexes with cytokinin derivatives: X-ray structure of 6-(3-methoxybenzylamino)purinium chloride monohydrate.
Trávnícek Z; Klanicová A; Popa I; Rolcík J
J Inorg Biochem; 2005 Mar; 99(3):776-86. PubMed ID: 15708799
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine.
De Azevedo WF; Leclerc S; Meijer L; Havlicek L; Strnad M; Kim SH
Eur J Biochem; 1997 Jan; 243(1-2):518-26. PubMed ID: 9030780
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structural characterization and antimicrobial activities of 12 zinc(II) complexes with four thiosemicarbazone and two semicarbazone ligands.
Kasuga NC; Sekino K; Ishikawa M; Honda A; Yokoyama M; Nakano S; Shimada N; Koumo C; Nomiya K
J Inorg Biochem; 2003 Aug; 96(2-3):298-310. PubMed ID: 12888265
[TBL] [Abstract][Full Text] [Related]
19. In vivo metabolism of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine in mice: glucosidation as the principal metabolic route.
Chmela Z; Veselý J; Lemr K; Rypka M; Hanus J; Havlícek L; Krystof V; Michnová L; Fuksová K; Lukes J
Drug Metab Dispos; 2001 Mar; 29(3):326-34. PubMed ID: 11181503
[TBL] [Abstract][Full Text] [Related]
20. Solid-state and solution-state coordination chemistry of the zinc triad with the mixed N,S donor ligand bis(2-methylpyridyl) sulfide.
Berry SM; Bebout DC; Butcher RJ
Inorg Chem; 2005 Jan; 44(1):27-39. PubMed ID: 15627357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
